Intrinsic Value of S&P & Nasdaq Contact Us

Body and Mind Inc. BMMJ OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
23/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Body and Mind Inc. (BMMJ) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 21/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $23M, +127.1%/yr average growth. Net income is $21M (loss), growing at -415.2%/yr. Net profit margin is -92.1% (negative). Gross margin is 25.3% (-3.2 pp trend).

Balance sheet: total debt is $20M with negative equity of -$10M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 1.21 (adequate). Debt-to-assets is 93.8%. Total assets: $21M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 25/100 (Fail), Moat 20/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

BMMJ SharesGrow Score Overview

28/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 25/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 20/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.01
Volume4.97K
Avg Volume (30D)7.47K
Market Cap$14.77K
Beta (1Y)-0.60
Share Statistics
EPS (TTM)-0.16
Shares Outstanding$134.35M
IPO Date2012-02-22
Employees142
CEOMichael Mills
Financial Highlights & Ratios
Revenue (TTM)$22.82M
Gross Profit$5.78M
EBITDA$-14.88M
Net Income$-21.03M
Operating Income$-7.67M
Total Cash$1.51M
Total Debt$19.89M
Net Debt$18.38M
Total Assets$21.21M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINUS09689V1008

Price Chart

BMMJ
Body and Mind Inc.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.01
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message